secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tarsus Pharmaceuticals, Inc. (TARS)
CIK:        0001819790
Form:       8-K
Filed at:   2023-06-15T23:59:59+00:00
Accession:  0001819790-23-000034
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tarsus hosts investor webcast on TP-03 commercialization strategy; no new material financial data disclosed
--------------------------------------------------------------------------------

- Company hosted Virtual Investor Webcast on June 15, 2023, with corporate presentation on TP-03 for Demodex blepharitis.
- Presentation posted to investor section of website; no specific financial results or guidance provided.
- No material changes to business or financial condition disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819790/000181979023000034/0001819790-23-000034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819790/000181979023000034/tars-20230615.htm
  HTML page:      https://secwatch.observer/filing/0001819790-23-000034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer